Future indications and clinical management for fecal microbiota transplantation (FMT) in immuno-oncology
Authors:
- 30 March 2023
- journal article
- review article
- Published by Elsevier in Seminars in Immunology
- Vol. 67, 101754
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Optimal screening and donor management in a public stool bankMicrobiome, 2015
- Establishing a Fecal Microbiota Transplant Service for the Treatment ofClostridium difficileInfectionClinical Infectious Diseases, 2015
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiotaScience, 2015
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacyScience, 2015
- Low Level Engraftment and Improvement following a Single Colonoscopic Administration of Fecal Microbiota to Patients with Ulcerative ColitisPLOS ONE, 2015
- Donor Recruitment for Fecal Microbiota TransplantationInflammatory Bowel Diseases, 2015
- Fecal Microbial Transplant Effect on Clinical Outcomes and Fecal Microbiome in Active Crohnʼs DiseaseInflammatory Bowel Diseases, 2015
- Fecal microbiota transplantation: effectiveness, complexities, and lingering concernsMucosal Immunology, 2014
- Fusobacterium in Colonic Flora and Molecular Features of Colorectal CarcinomaCancer Research, 2014
- Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in MiceScience, 2013